CancerNetwork, an arm of the prestigious journal Oncology, joined LFSA at the 7th International LFS Association Symposium to report on the latest advances in LFS research and clinical therapies. Reflected here are highlights of presentations by global experts.
Co-chair of the symposiumm, Suzanne P. MacFarland, MD, shared a thought-provoking presentation on liquid biopsy and the need to verify the potential benefit of this modality.
“Liquid biopsy is a way to find cancer DNA in the blood, essentially, and detect it before it’s symptomatic and before we can see it on scans. There are some excellent studies of liquid biopsy to show that it can pick up cancer up to a year in advance of it showing up clinically…There is a need right now to develop this kind of test and test it within this group of patients.”
MacFarland, an attending physician in the Division of Oncology and Cancer Predisposition Program at Children’s Hospital of Philadelphia, discussed the need to fund a clinical trial to assess liquid biopsy for those with LFS in her talk with CancerNetwork on Liquid Biopsy Imaging May Show Benefit in Li-Fraumeni Syndrome Screening
